Prothena Corp. plc buy Chardan Capital
Start price
21.02.25
/
50%
€16.20
Target price
21.02.26
€38.18
Performance (%)
-66.67%
Price
15.07.25
€5.40
Summary
This prediction is currently active. Massive losses of -66.67% have been the result for the BUY prediction by Chardan_Capital. This prediction currently runs until 21.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Prothena Corp. plc | -3.571% | -3.571% |
| iShares Core DAX® | -0.727% | 2.783% |
| iShares Nasdaq 100 | 1.839% | 5.294% |
| iShares Nikkei 225® | -2.033% | -0.196% |
| iShares S&P 500 | 1.334% | 4.044% |
Comments by Chardan_Capital for this prediction
In the thread Prothena Corp. plc diskutieren
Prothena Co. plc (NASDAQ: PRTA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $40.00 price target on the stock.
Ratings data for PRTA provided by MarketBeat
Stopped prediction by Chardan_Capital for Prothena Corp. plc
Prothena Corp. plc
Start price
Target price
Perf. (%)
€4.64
27.05.25
27.05.25
€15.80
27.05.26
27.05.26
16.38%
15.07.25
15.07.25
Prothena Corp. plc
Start price
Target price
Perf. (%)
€7.10
09.05.25
09.05.25
€35.67
09.05.26
09.05.26
-23.94%
15.07.25
15.07.25
Prothena Corp. plc
Start price
Target price
Perf. (%)
€14.50
20.12.24
20.12.24
€38.43
20.12.25
20.12.25
-62.76%
15.07.25
15.07.25